BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 6360787)

  • 1. Inhibition of gastric acid secretion by selective and nonselective anticholinergics.
    Feldman M
    Gastroenterology; 1984 Feb; 86(2):361-6. PubMed ID: 6360787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antacids and anticholinergics in the treatment of duodenal ulcer.
    Walan A
    Clin Gastroenterol; 1984 May; 13(2):473-99. PubMed ID: 6086186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Use of gastrocepin in middle-aged and elderly patients with peptic ulcer].
    Kapitanenko AM; Shastin IV; Karnaukhov IuN; Merkur'ev ND; Smirnov PA
    Klin Med (Mosk); 1986 Mar; 64(3):95-6. PubMed ID: 3520141
    [No Abstract]   [Full Text] [Related]  

  • 4. Cholinergic control of gastric acid secretion in man.
    Konturek SJ
    Scand J Gastroenterol Suppl; 1982; 72():1-5. PubMed ID: 6753111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pirenzepine: a selective anticholinergic for peptic ulcer.
    Drug Ther Bull; 1985 Apr; 23(8):29-31. PubMed ID: 3888582
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pirenzepine--an anticholinergic agent with selective antimuscarinic properties].
    Dotevall G; Jaup BH; Stockbrügger RW
    Lakartidningen; 1982 Oct; 79(41):3671-3. PubMed ID: 6897434
    [No Abstract]   [Full Text] [Related]  

  • 7. [Selective muscarinic receptor antagonists].
    Kishimoto S; Kajiyama G; Miyoshi A
    Nihon Rinsho; 1984 Jan; 42(1):114-9. PubMed ID: 6371305
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacologic control of gastric acid secretion in peptic ulcer.
    Konturek SJ
    Mt Sinai J Med; 1983; 50(6):457-67. PubMed ID: 6141524
    [No Abstract]   [Full Text] [Related]  

  • 9. Pirenzepine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in peptic ulcer disease and other allied diseases.
    Carmine AA; Brogden RN
    Drugs; 1985 Aug; 30(2):85-126. PubMed ID: 3928324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of pirenzepine on L--amino acids stimulated gastric acid secretion and serum gastrin levels in peptic ulcer disease in men.
    Bertoglio S; Anfossi A; Arnulfo G; Valentini P; Berti Riboli E
    Scand J Gastroenterol Suppl; 1982; 72():179-84. PubMed ID: 6957988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Agents with tricyclic structures for treating peptic ulcer disease.
    Berardi RR; Caplan NB
    Clin Pharm; 1983; 2(5):425-31. PubMed ID: 6354568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [MI cholinergic receptors of gastric secretion: current status].
    Vatier J
    J Pharmacol; 1985; 16 Suppl 2():145-69. PubMed ID: 2867250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions of cimetidine and pirenzepine on peptone-stimulated gastric acid secretion in man.
    Londong W; Londong V; Prechtl R; Weber T; von Werder K
    Scand J Gastroenterol Suppl; 1980; 66():103-14. PubMed ID: 6941373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pirenzepine in the treatment of peptic ulcer disease. Review and commentary.
    Bianchi Porro G; Petrillo M
    Scand J Gastroenterol Suppl; 1982; 72():229-36. PubMed ID: 6753117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of atropine and pirenzepine on healing of gastric ulcer induced by mucosal excision in rats.
    Sano M; Kitagawa H; Fujiwara M
    Clin Ther; 1985; 7(3):380-9. PubMed ID: 3838920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Present status and future perspectives of muscarinic receptor antagonists.
    Londong W
    Scand J Gastroenterol Suppl; 1986; 125():55-60. PubMed ID: 2881347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of M1 receptor antagonists.
    Stockbrügger RW
    Pharmacology; 1988; 37 Suppl 1():54-63. PubMed ID: 3070580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimuscarinic drugs.
    Stockbrügger RW
    Methods Find Exp Clin Pharmacol; 1989; 11 Suppl 1():79-86. PubMed ID: 2657292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholinergically stimulated gastric acid secretion is mediated by M(3) and M(5) but not M(1) muscarinic acetylcholine receptors in mice.
    Aihara T; Nakamura Y; Taketo MM; Matsui M; Okabe S
    Am J Physiol Gastrointest Liver Physiol; 2005 Jun; 288(6):G1199-207. PubMed ID: 15691866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Moderate reduction of gastric acid secretion in the treatment of peptic ulcer disease.
    Jaup BH
    Scand J Gastroenterol Suppl; 1985; 111():36-40. PubMed ID: 2861651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.